Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon and Therapeutic Hypothermia After Successful Cardiopulmonary Resuscitation
2010-022679-71Phase 2Terminated
- Sponsor
- Clinical Trials Center Aachen
- Start
- Dec 2010
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of xenon in cardiac arrest (SCA) (2 arms), sponsored by Clinical Trials Center Aachen. Primary endpoint: Safety and efficacy of xenon ventilation within 2 hours after successful cardiopulmonary resuscitation. Started Dec 2010; status: terminated.
02
Drugs
xenon
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on 2010-022679-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022679-71.